Alkylating Agents Flashcards

1
Q

What is the largest class of anticancer drugs?

A

Alkylating agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alkylating agents follow the same general mechanism, explain this mechanism.

A

They all follow the same general mechanism; they are all electrophilic molecules that covalently modify nucleophilic molecules in cells. DNA is the most important adduct (N7 and O6 of Guanine) for anticancer properties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of alkylating agents?

A

Monofunctional and bifunctional.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe monofunctional alkylating agents.

A

Alkylating agents that cause single strand DNA breaks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe bifunctional alkylating agents.

A

Alkylating agents that inhibit DNA replication and transcription by cross-linking DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give the subtypes of alkylating agents.

A
  • Nitrogen mustards.
  • Nitroso-ureas.
  • CIS Platinum Compounds.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give some examples of nitrogen mustards.

A

Mechlorethamine (Mustargen), Chlorambucil (Leukeran), Cyclophosphamide (Cytoxan).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is mustargen used to treat?

A

This is used for Hodgkin’s/other lymphomas and chronic leukemias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mustargen is used as part of which combination therapy/regimen?

A

The MOPP regimen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drugs does the MOPP regimen include?

A

Mechlorethamine, vinvristine (Oncovin), procarbazine, prednisolone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which drug is the prototype for the mustards (alkylating agents)?

A

Mustargen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What percentage response rate is seen in patients treated with mustargen?

A

80%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage cure rate is seen in patients treated with mustargen?

A

50%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the toxic effects of mustargen?

A

Its toxicity profile includes nausea and vomiting. The effects of dose limiting toxicity (DLT) are bone marrow suppression affecting white blood cells (esp. granulocytes).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is the max bone marrow suppression seen with mustargen seen clinically? When is recovery seen?

A

10-12 days. Around 42 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the half life of mustargen?

A

Less than 30 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is mustargen administered?

A

In a free-flowing catheter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some analogues of mustargen?

A
  • Chlorambucil (Leukeran).

* Melphalan (Alkeran) – Used in myeloma (longer half-life, PO).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is chlorambucil used for?

A

This drug is used for the treatment of chronic lymphocytic leukaemia and malignant lymphomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the main side effect of chlorambucil?

A

It can lead to cumulative bone marrow toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What type of electrophilic reaction do the mustards undergo?

A

SN2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is cyclophosphamide used to treat?

A

Cyclophosphamide is a prodrug used for the treatment of malignant lymphomas and various carcinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which single drug is the most widely used alkylating agent?

A

Cyclophosphamide.

24
Q

Which drugs are included in the CMF anticancer regimen?

A

Cyclophosphamide, methotrexate, flurouricil.

25
Q

How does the CMF regimen increase 7 year survival rates?

A

31% to 49%.

26
Q

Cyclophosphamide has a better toxocity profile than mustargen, what specifically is seen in this regard?

A

Better bone marrow recovery seen.

27
Q

How long does cyclophosphamide treatment last at a time?

A

10-12 days.

28
Q

How long after treatment with cyclophosphamide is taken for recovery?

A

21 days.

29
Q

How is cyclophoisphamide administered?

A

Parenterally.

30
Q

Cells resistant to cyclophosphamide may contain which chemical compound?

A

Aldehyde oxidase.

31
Q

Give some examples of nitrosoureas.

A
  • Bis-chloro-nitrosourea (Carmustine, BCNU).

* Chloroethylcyclohexylnitrosourea (Lomustine, CCNU).

32
Q

What are BCNU and CCNU used to treat?

A

BCNU and CCNU are both used for brain tumours, Hodgkin’s disease, and melanoma.

33
Q

What properties of BCNU and CCNU make them viable for the treatment of brain tumours?

A

They are lipid soluble which makes them CNS active and a possible drug for treating brain tumours as they can pass the BBB.

34
Q

What is the mode of action for the nitrosoureas such as BCNU and CCNU?

A

There method of action includes the alkylation of the O6 of Guanine (comparatively, the alkylation by mustards is the N7 of guanine).

35
Q

Why should care be taken when treating women with nitrosoureas?

A

Care should be taken with pregnant women or women planning on becoming pregnant as these drugs are teratogenic.

36
Q

What type of electrophilic reaction do the nitrosoureas undergo?

A

SN1.

37
Q

BCNU is used in the treatment of glioblastome. With surgery and radiation treatment, how long can this increase lifespan?

A

20 weeks to 50 weeks.

38
Q

BCNU has a high toxicity, therefor how long should treatment last?

A

A max length of 28 days.

39
Q

How long does recovery from the toxic effects of BCNU take?

A

42 days?

40
Q

How is BCNU administered?

A

By injection.

41
Q

What is the common name for BCNU?

A

Carmustin.

42
Q

Why may haematological toxicity persist with the use of BCNU?

A

BCNU is very lipophilic and has low ionisation at physiological pH, this gives a risk of haematological toxicity persisting due to storage in the liver.

43
Q

How is CCNU given?

A

Orally.

44
Q

What is a new non-nitrosourea which is used frequently in the treatment of glioblastoma?

A

Temozolomide (Temodar).

45
Q

What is glioblastoma?

A

Glioblastoma, also known as glioblastoma multiforme (GBM), is the most aggressive cancer that begins within the brain. Initially, signs and symptoms of glioblastoma are non-specific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke.

46
Q

At what dose is temozolomide administered?

A

200mg/m^2 daily for 5 days.

47
Q

What is the active metabolite of temozolomide?

A

MTIC.

48
Q

What is the lead structure for the cis-platinum compounds?

A

Cisplatin.

49
Q

In what type of therapy is cisplatin most commonly used?

A

Combination therapy.

50
Q

In combination therapy, which cis-platinum compound is the first line treatment for colon cancer?

A

Cisplatin.

51
Q

What is the common name for cisplatin?

A

Platinol.

52
Q

What is the percentage cure rate for cisplatin when used in testicular cancer?

A

85%.

53
Q

What is the toxicity profile of cisplatin?

A

Its toxicity profile shows nephrotoxicity and hearing loss at the high end of doses.

54
Q

Give some analogues of cisplatin.

A
  • Carboplatin (Parbaplatin).

* Oxaliplatin (Eloxatin).

55
Q

Where do nitrosoureas alkylate cytosine?

A

3’N.